Indexed in Journament

Precision Medicine Communications

ISSN 2958-583X (Online), 2958-5821 (Print)· EN

Login or register to claim ownership or editorship of this journal.
12
Articles Indexed

About This Journal

Precision Medicine Communications is a biannual, peer-reviewed, print and electronic journal, which is dedicated to the rapid publication of original research on pharmacogenomics and its clinical applications. It especially considers studies investigating the effects of genetic variability on drug toxicity and efficacy, identification and functional characterization of polymorphisms relevant to the pharmacological action and adverse effects of a drug, integration of new developments in the genome project and proteomics into clinical medicine, pharmacology, and therapeutics, clinical implementation of pharmacogenomics, identification of novel genomic targets for drug development, economics of genome-guided interventions, clinical implementation of pharmacogenomics, pharmacogenomics in developing countries, companion diagnostics and drug development. The journal provides an integrated forum for all players involved - academic and clinical researchers, pharmaceutical companies, regulatory authorities, healthcare management organizations, patient organizations, and others in the healthcare community. Precision Medicine Communications assists these parties to shape the future of medicine by providing a platform for expert commentary and analysis.
Short Name Prec. Med. Comm.
Abbreviated Name PMC
ISSN 2958-583X (Online), 2958-5821 (Print)
URL https://rootspress.org/journals/index.php/PMC
Author Instructions Sagheer.scps@stmu.edu.pk

Tools & Certificate of Indexing

Publications Per Year

Articles (12)

2022
Escitalopram Use in Depression & the Influence of Genetic Variations on Its Safety & Efficacy
Vol. 2 , No. 02 , pp. 119-132
362 views DOI Abstract
2022
Single Nucleotide Polymorphisms Associated with the Safety and Efficacy of Anti-Gout Medications
Vol. 2 , No. 02 , pp. 133-154
295 views DOI Abstract
2022
The Genetic Influence on the Antihypertensive and Uricosuric Actions of Losartan
Vol. 2 , No. 02 , pp. 155-167
204 views DOI Abstract
2022
Evidence-Based Prioritization and Scoring of Genomic Loci Interacting with Pioglitazone Therapeutic Response in Diabetic Patients.
Vol. 2 , No. 02 , pp. 91-108
182 views DOI Abstract
2022
Cytochrome P450 2C19*2 Genetic Polymorphism in Patients with Acute Coronary Syndrome
Vol. 2 , No. 02 , pp. 109-117
181 views DOI Abstract
2022
Anti-TNF-α Treatment Response in Ankylosing Spondylitis Depends on Gut Microbiota
Vol. 2 , No. 02 , pp. 85-89
150 views DOI Abstract
2022
Plasma Simvastatin Variations with CYP3A4*22 and CYP3A5*3
Vol. 2 , No. 02 , pp. 85-89
136 views DOI Abstract
2022
Precision Medicine and Cancer Chemotherapy
Vol. 2 , No. 02 , pp. 79-79
128 views DOI Abstract
2022
Resistance of Breast Cancer Cells to Paclitaxel Elucidated
Vol. 2 , No. 02 , pp. 85-89
101 views DOI Abstract
2022
Prediction of Toxicities Induced by Sorafenib and Regorafenib
Vol. 2 , No. 02 , pp. 85-89
92 views DOI Abstract
2022
The Genetic Influence on the Antihypertensive and Uricosuric Actions of Losartan
Vol. 2 , No. 02 , pp. 155-167
204 views DOI Abstract
2022
Single Nucleotide Polymorphisms Associated with the Safety and Efficacy of Anti-Gout Medications
Vol. 2 , No. 02 , pp. 133-154
295 views DOI Abstract
2022
Escitalopram Use in Depression & the Influence of Genetic Variations on Its Safety & Efficacy
Vol. 2 , No. 02 , pp. 119-132
362 views DOI Abstract
2022
Cytochrome P450 2C19*2 Genetic Polymorphism in Patients with Acute Coronary Syndrome
Vol. 2 , No. 02 , pp. 109-117
181 views DOI Abstract
2022
Evidence-Based Prioritization and Scoring of Genomic Loci Interacting with Pioglitazone Therapeutic Response in Diabetic Patients.
Vol. 2 , No. 02 , pp. 91-108
182 views DOI Abstract
2022
Prediction of Toxicities Induced by Sorafenib and Regorafenib
Vol. 2 , No. 02 , pp. 85-89
92 views DOI Abstract
2022
Anti-TNF-α Treatment Response in Ankylosing Spondylitis Depends on Gut Microbiota
Vol. 2 , No. 02 , pp. 85-89
150 views DOI Abstract
2022
Plasma Simvastatin Variations with CYP3A4*22 and CYP3A5*3
Vol. 2 , No. 02 , pp. 85-89
136 views DOI Abstract
2022
Resistance of Breast Cancer Cells to Paclitaxel Elucidated
Vol. 2 , No. 02 , pp. 85-89
101 views DOI Abstract
2022
Predicting Stroke risk in a Chinese Han Population From Liaoning, China
Vol. 2 , No. 02 , pp. 85-89
20 views DOI Abstract
0
Overall
Not Rated
0
0
0
0
0
0
0
0
0
0
0